Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences


Featured Articles

Endotoxin Control Strategies for Parenteral Drug Product Manufacturing

Robert Simler Associate Director, Engineering and Technology Biogen, Cambridge, MA, USA 

Current Status of Analytical Techniques for Characterization of Protein Stability

Dr. Sanket Patke, Research Investigator at Bristol-Myers Squibb with Dr. Joshua Stillahn and Dr Manning

Expanding Adoption of Single-Use Systems Drives Need for Wider Range of Sterile Connector Technologies

James Barry, Director of Marketing, Americas, Pall Biotech

Trends in Single-Use Mixing Technologies and Insight into Pall and Lonza Ibex® Solutions

View All Featured Articles

Headline News

Jemperli achieves 76% complete response rate in Phase II rectal cancer trial


Ris-Rez cuts progression risk by 67% in Phase III relapsed osteosarcoma trial


RYBREVANT FASPRO combination shows 77% response rate in first-line advanced head and neck cancer


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Innovation in Biomanufacturing Plants

Presented by Chris Chen PhD, CEO at WuXi Biologics and Dr. Sébastien Ribault, Senior Director, Global Delivery and Sales, BioReliance® End-to-End Solutions at Merck.
20th June 2019


Developability Assessment of Therapeutic Proteins – A Toolbox for Tackling Increasing Complexity

Presented by Thorsten Lorenz, Team Head Developability Assessment Biologics at Novartis and Beate Kern, Product Manager at NanoTemper Technologies
27th September 2018


Chemical and Physical Transformation Monitoring by Raman and IR Spectroscopies in Pharmaceutical Development

Presented by John Wasylyk, Senior Principal Scientist at Bristol-Myers Squibb and Karen Esmonde-White, Senior Marcom Specialist at Kaiser Optical Systems Inc.
01st July 2019


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia